mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
0.25 |
8e-16 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.26 |
2e-15 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
5e-14 |
mRNA |
BX-912 |
GDSC1000 |
pan-cancer |
AAC |
0.23 |
2e-13 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
9e-13 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
1e-12 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
2e-12 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
2e-12 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
3e-12 |
mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
5e-12 |